Even with today’s best available medicine, over 80% of patients on life support for 4 or more days will develop clinical forms of delirium resulting in an added cost of $65,000 per occurrence and 300% higher mortality rate due to the inherent nature of IV sedation. Alternatively, ICU doctors, which are mostly anesthesiologists worldwide, would prefer to use the same inhaled drugs used in the OR which don’t have these same side effects. But today’s anesthesia machines are large, complex and manually controlled.
Medical Conservation Devices ($500,000 43North Runner Up in 2014) has developed a next generation anesthesia with endorsements from the top worldwide physician in ICU delirium. MCD has filed its 510k and received initial FDA comments. The company is raising $1 million to achieve initial product launch by year end 2016. Visit http://www.firstwavetechnologies.com/projects/mcd.htm for additional information.
**Click here to view the original article.**